|
BMS-986446 Clinical Trials
1 actively recruiting trial across 1 location
Also known as: Moponetug, PRX005
Pipeline
Phase 1: 1
Top Sponsors
- Bristol-Myers Squibb1
Indications
- Alzheimer's Disease1
- Healthy Participants1
Anaheim, California1 trial
A Study to Evaluate the Drug Levels, Absolute Bioavailability, Safety, Tolerability, and Immunogenicity of Single-Dose of BMS-986446 in Healthy Adults After Single-dose Administration, and Participants With Early Alzheimer's Disease After Multiple Dose Administration
CenExel ACT (Formerly Anaheim Clinical Trials; LLC)
Phase 1
Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.
This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.